Your browser doesn't support javascript.
loading
Laboratory Testing Implications of Risk-Stratification and Management of COVID-19 Patients.
Liu, Caidong; Wang, Ziyu; Wu, Wei; Xiang, Changgang; Wu, Lingxiang; Li, Jie; Hou, Weiye; Sun, Huiling; Wang, Youli; Nie, Zhenling; Gao, Yingdong; Zhang, Ruisheng; Tang, Haixia; Wang, Qianghu; Li, Kening; Xia, Xinyi; Li, Pengping; Wang, Shukui.
Afiliación
  • Liu C; Department of Laboratory Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Wang Z; Department of Bioinformatics, Nanjing Medical University, Nanjing, China.
  • Wu W; Department of Bioinformatics, Nanjing Medical University, Nanjing, China.
  • Xiang C; Department of Laboratory Medicine, First People's Hospital of Jiangxia District of Wuhan, Wuhan, China.
  • Wu L; Department of Bioinformatics, Nanjing Medical University, Nanjing, China.
  • Li J; Department of Bioinformatics, Nanjing Medical University, Nanjing, China.
  • Hou W; Department of Laboratory Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Sun H; General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Wang Y; Department of Laboratory Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Nie Z; Department of Laboratory Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Gao Y; Department of Laboratory Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Zhang R; Department of Laboratory Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Tang H; Department of Critical Care Medicine, Luan Hospital of Chinese Medicine, Lu'an, China.
  • Wang Q; Department of Bioinformatics, Nanjing Medical University, Nanjing, China.
  • Li K; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing Medical University, Nanjing, China.
  • Xia X; Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, Nanjing, China.
  • Li P; Department of Bioinformatics, Nanjing Medical University, Nanjing, China.
  • Wang S; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing Medical University, Nanjing, China.
Front Med (Lausanne) ; 8: 699706, 2021.
Article en En | MEDLINE | ID: mdl-34485335
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Med (Lausanne) Año: 2021 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Med (Lausanne) Año: 2021 Tipo del documento: Article País de afiliación: China